A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.
about
Analysis of the lung microbiome in the "healthy" smoker and in COPDLung microbiology and exacerbations in COPDThe microbiome of the lungAcute exacerbation of COPDBacterial-viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospectsCOPD and the microbiomeMicrobiome and Asthma: What Have Experimental Models Already Taught Us?Microbiology and ecology are vitally important to premedical curriculaBiomarkers of progression of chronic obstructive pulmonary disease (COPD)Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs.Pulmonary-intestinal cross-talk in mucosal inflammatory diseaseThe lung microbiome in 2015: a window on chronic lung diseasesApplication of phylogenetic microarrays to interrogation of human microbiotaThe respiratory microbiome: an underappreciated player in the human response to inhaled pollutants?X-box binding protein 1 (XBP1s) is a critical determinant of Pseudomonas aeruginosa homoserine lactone-mediated apoptosisLung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET studySingle-molecule long-read 16S sequencing to characterize the lung microbiome from mechanically ventilated patients with suspected pneumonia.Carbon and Sulfur Cycling below the Chemocline in a Meromictic Lake and the Identification of a Novel Taxonomic Lineage in the FCB Superphylum, Candidatus Aegiribacteria.Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.The role of the bacterial microbiome in lung diseaseComparative analyses of the bacterial microbiota of the human nostril and oropharynx.Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.Significance of the microbiome in chronic obstructive pulmonary disease.Lung Microbiota and Its Impact on the Mucosal Immune Phenotype.Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.Development of an ex vivo porcine lung model for studying growth, virulence, and signaling of Pseudomonas aeruginosa.Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.Reanalysis and simulation suggest a phylogenetic microarray does not accurately profile microbial communitiesAspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients.Oral and airway microbiota in HIV-infected pneumonia patients.Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary diseaseA comparison between droplet digital and quantitative PCR in the analysis of bacterial 16S load in lung tissue samples from control and COPD GOLD 2Novosphingobium and its potential role in chronic obstructive pulmonary diseases: insights from microbiome studies.The lung microbiome in moderate and severe chronic obstructive pulmonary diseaseProbiotic manipulation of the gastrointestinal microbiotaProfiling bacterial community in upper respiratory tracts.Asthma microbiome studies and the potential for new therapeutic strategiesAbundant DNase I-sensitive bacterial DNA in healthy porcine lungs and its implications for the lung microbiomeAnalysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
P2860
Q21091065-1F6E4554-8623-408F-97DE-E94B955481E1Q22305860-F1BE8936-2734-47B4-B2E2-46A00CB14075Q24602074-9A141A54-971F-4F3C-96F8-599FADE1B130Q26749302-E35F20F9-0C21-4BEF-830D-7B23223210E2Q26752882-7651B75E-1492-43E9-A7C7-C898B39EFDF4Q26768514-E6B27547-33BB-4F99-B932-85FCD169D2A1Q26798677-D1FE40DB-BCE8-4D48-BAC5-B01D6C3F2D54Q26801329-2415B234-34EE-4F00-9066-060F85951688Q26996356-7B5541B0-E258-442C-A1E5-0F8B7C4A6660Q27687411-3044CA14-A0D9-49C8-93B8-4BF609AE5782Q27693862-0A49E9AA-6342-479A-AEA7-B83A6F6338E2Q28086865-756C4F70-3DD0-4EAF-A2BC-64CBF3CACDF3Q28394847-04EEDBB2-43F9-41D7-B30A-6AFB038562F8Q28396321-87EE26EA-0240-4BDB-8E9F-E83BAADCCEE3Q28535497-2D049BF8-F9EC-4A64-A66A-A4725FE5E9DEQ30384494-A32BAE48-8DCA-4CF9-B3A1-C361A66E937CQ30619426-B391E9DF-C598-43E1-8E59-478516C94166Q31097568-29CC6B4E-F4B5-4335-B858-AD364FB9A164Q31134621-FA8B5841-D0BF-4226-95B1-C9CCBD669AB2Q33554623-86FE4289-26C1-45C1-8E20-3D36FE7A27CBQ33677712-473BB15E-CC76-488C-AC2B-DD81D8AD030CQ33782854-2952ADA2-9885-4207-B0AF-68B5EFDFEB3FQ33817613-8A37229B-74FE-448E-82E8-7648744ADB3EQ33833225-2109C31E-85AE-41FA-9C03-5D9B096E1FB7Q34058686-A49953CA-903B-46F6-8A45-F70246FB79CCQ34059034-13731D22-C70B-47ED-A8C9-56689E39F5D9Q34181466-ED579C4E-5805-4F0B-8F16-4F4551DDD347Q34212029-C7E48520-8E88-4BDB-9BFD-1B3ADB99D73DQ34277932-620E2AB7-A9F0-4311-B10A-79DC4A7F54A2Q34325140-F80CB8AA-8852-4DA7-A35A-97D6147BEC86Q34351419-48C7C2B4-C908-471C-8716-5CECCCBF3C2EQ34352146-DAA2B673-8D6F-49F1-A730-86F63CC56E99Q34395556-B62CE2DA-A9F9-4239-8CDB-20BA367EC98CQ34448176-ADDB70D7-1E0C-48B4-8C51-C96272150353Q34503660-253D52ED-8106-415E-A7C9-539BB4FFBDA2Q34537481-B0628FD1-2A33-410F-AE7B-53F249DDDD96Q34741123-678C7393-DAE4-4A7D-8BF2-063C20CCA0A8Q34843160-74958D4E-FF6D-49E9-AF0E-2E8DBD35E50AQ34847848-12770EDE-3416-43F7-8114-C113C3B9DF96Q34986902-DFBCD5FD-65F7-44EA-ACCC-B361B8A9B10F
P2860
A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A persistent and diverse airwa ...... lmonary disease exacerbations.
@ast
A persistent and diverse airwa ...... lmonary disease exacerbations.
@en
type
label
A persistent and diverse airwa ...... lmonary disease exacerbations.
@ast
A persistent and diverse airwa ...... lmonary disease exacerbations.
@en
prefLabel
A persistent and diverse airwa ...... lmonary disease exacerbations.
@ast
A persistent and diverse airwa ...... lmonary disease exacerbations.
@en
P2093
P2860
P356
P1476
A persistent and diverse airwa ...... ulmonary disease exacerbations
@en
P2093
Eugenia Kim
Jeanine P Wiener-Kronish
Susan V Lynch
Yvonne J Huang
P2860
P356
10.1089/OMI.2009.0100
P577
2010-02-01T00:00:00Z